跳至主要内容
临床试验/ISRCTN72676102
ISRCTN72676102已完成不适用

Dutch randomised trial comparing standard catheter-directed thrombolysis versus ultrasound-accelerated thrombolysis for thromboembolic infra-inguinal disease (DUET)

St Antonius Hospital Nieuwegein (Netherlands)0 个研究点目标入组 60 人开始时间: 2009年12月8日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Both males and females, greater than 18 years and less than 85 years old
  • 2. Patients with recently (between 1 and 7 weeks) thrombosed femoro-popliteal or femoro-crural native arteries or femoro-popliteal or femoro-crural venous or prosthetic bypass grafts with ischaemic complaints
  • 3. Patients with acute lower limb ischaemia class I and IIa according to the Rutherford classification
  • 4. Patients understand the nature of the procedure and provide written informed consent, prior to enrolment in the study

排除标准

  • 1. Patients with isolated common femoral artery thrombosis including the origin of the superficial femoral artery and profunda femoral artery
  • 2. Patients with localised (less than 5 cm) emboli/occlusions in the native femoro-popliteal arteries
  • 3. Patients with clinical complaints of acute lower limb ischaemia due to thrombosis of the femoro-popliteal or femoro-crural native arteries or femoro-popliteal or femoro-crural venous or prosthetic bypass grafts less than 1 week and greater than 7 weeks
  • 4. Patients with acute lower limb ischaemia class IIb and III according to the Rutherford classification
  • 5. Patients for whom antiplatelet therapy, anticoagulants or thrombolytic drugs are contra-indicated
  • 6. Recent (less than 6 weeks) ischaemic stroke or cerebral bleeding
  • 7. Patients with recent (less than 6 weeks) surgery
  • 8. Severe hypertension (diastolic blood pressure greater than 110 mmHg, systolic blood pressure greater than 200 mmHg)
  • 9. Current malignancy
  • 10. Patients with a history of prior life-threatening contrast medium reaction
  • 11. Patients with uncorrected bleeding disorders (gastro-intestinal ulcer, menorrhagia, liver failure)
  • 12. Female patients with child bearing potential not taking adequate contraceptives or currently breastfeeding
  • 13. Pregnancy
  • 14. Any patient considered to be haemodynamically unstable at onset of procedure
  • 15. Patients refusing treatment
  • 16. Patients currently participating in another investigational drug or device study that have not completed the entire follow up period
  • 17. Patients less than 18 years or greater than 85 years old
  • 18. Severe co-morbid condition with life expectancy less than 1 month
  • 19. Contra-indication for magnetic resonance imaging (MRI)

研究者

发起方
St Antonius Hospital Nieuwegein (Netherlands)

相似试验